Advertisement
Research Article

Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 Influenza

  • Cameron P Simmons equal contributor,

    equal contributor Contributed equally to this work with: Cameron P Simmons, Nadia L Bernasconi, Amorsolo L Suguitan Jr., Kimberly Mills

    Affiliation: Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam

    X
  • Nadia L Bernasconi equal contributor,

    equal contributor Contributed equally to this work with: Cameron P Simmons, Nadia L Bernasconi, Amorsolo L Suguitan Jr., Kimberly Mills

    Affiliation: Institute for Research in Biomedicine, Bellinzona, Switzerland

    X
  • Amorsolo L Suguitan Jr. equal contributor,

    equal contributor Contributed equally to this work with: Cameron P Simmons, Nadia L Bernasconi, Amorsolo L Suguitan Jr., Kimberly Mills

    Affiliation: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Kimberly Mills equal contributor,

    equal contributor Contributed equally to this work with: Cameron P Simmons, Nadia L Bernasconi, Amorsolo L Suguitan Jr., Kimberly Mills

    Affiliation: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Jerrold M Ward,

    Affiliation: Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Nguyen Van Vinh Chau,

    Affiliation: Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam

    X
  • Tran Tinh Hien,

    Affiliation: Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam

    X
  • Federica Sallusto,

    Affiliation: Institute for Research in Biomedicine, Bellinzona, Switzerland

    X
  • Do Quang Ha,

    Affiliation: Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam

    X
  • Jeremy Farrar,

    Affiliation: Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam

    X
  • Menno D de Jong,

    Affiliation: Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam

    X
  • Antonio Lanzavecchia mail,

    To whom correspondence should be addressed. E-mail: lanzavecchia@irb.unisi.ch (AL); ksubbarao@niaid.nih.gov (KS)

    Affiliation: Institute for Research in Biomedicine, Bellinzona, Switzerland

    X
  • Kanta Subbarao mail

    To whom correspondence should be addressed. E-mail: lanzavecchia@irb.unisi.ch (AL); ksubbarao@niaid.nih.gov (KS)

    Affiliation: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Published: May 29, 2007
  • DOI: 10.1371/journal.pmed.0040178

Reader Comments (0)

Post a new comment on this article